Literature DB >> 29364211

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.

Julie Bolcaen1, Benedicte Descamps2, Tom Boterberg3, Christian Vanhove2, Ingeborg Goethals4.   

Abstract

For decades, small animal radiation research was mostly performed using fairly crude experimental setups applying simple single-beam techniques without the ability to target a specific or well-delineated tumor volume. The delivery of radiation was achieved using fixed radiation sources or linear accelerators producing megavoltage (MV) X-rays. These devices are unable to achieve sub-millimeter precision required for small animals. Furthermore, the high doses delivered to healthy surrounding tissue hamper response assessment. To increase the translation between small animal studies and humans, our goal was to mimic the treatment of human glioblastoma in a rat model. To enable a more accurate irradiation in a preclinical setting, recently, precision image-guided small animal radiation research platforms were developed. Similar to human planning systems, treatment planning on these micro-irradiators is based on computed tomography (CT). However, low soft-tissue contrast on CT makes it very challenging to localize targets in certain tissues, such as the brain. Therefore, incorporating magnetic resonance imaging (MRI), which has excellent soft-tissue contrast compared to CT, would enable a more precise delineation of the target for irradiation. In the last decade also biological imaging techniques, such as positron emission tomography (PET) gained interest for radiation therapy treatment guidance. PET enables the visualization of e.g., glucose consumption, amino-acid transport, or hypoxia, present in the tumor. Targeting those highly proliferative or radio-resistant parts of the tumor with a higher dose could give a survival benefit. This hypothesis led to the introduction of the biological tumor volume (BTV), besides the conventional gross target volume (GTV), clinical target volume (CTV), and planned target volume (PTV). At the preclinical imaging lab of Ghent University, a micro-irradiator, a small animal PET, and a 7 T small animal MRI are available. The goal was to incorporate MRI-guided irradiation and PET-guided sub-volume boosting in a glioblastoma rat model.

Entities:  

Mesh:

Year:  2017        PMID: 29364211      PMCID: PMC5908400          DOI: 10.3791/56601

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).

Authors:  Julie Bolcaen; Benedicte Descamps; Karel Deblaere; Tom Boterberg; Giorgio Hallaert; Caroline Van den Broecke; Elke Decrock; Anne Vral; Luc Leybaert; Christian Vanhove; Ingeborg Goethals
Journal:  J Neurooncol       Date:  2014-07-29       Impact factor: 4.130

Review 3.  Small animal radiotherapy research platforms.

Authors:  Frank Verhaegen; Patrick Granton; Erik Tryggestad
Journal:  Phys Med Biol       Date:  2011-05-26       Impact factor: 3.609

Review 4.  Small animal image-guided radiotherapy: status, considerations and potential for translational impact.

Authors:  K T Butterworth; K M Prise; F Verhaegen
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

5.  Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors.

Authors:  Weilian Yang; Tianyao Huo; Rolf F Barth; Nilendu Gupta; Michael Weldon; John C Grecula; Brian D Ross; Benjamin A Hoff; Ting-Chao Chou; Julia Rousseau; Hélène Elleaume
Journal:  J Neurooncol       Date:  2010-06-25       Impact factor: 4.130

6.  FET-PET for malignant glioma treatment planning.

Authors:  Maximilian Niyazi; Julia Geisler; Axel Siefert; Silke Birgit Schwarz; Ute Ganswindt; Sylvia Garny; Oliver Schnell; Bogdana Suchorska; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn; Peter Bartenstein; Christian la Fougère; Claus Belka
Journal:  Radiother Oncol       Date:  2011-03-30       Impact factor: 6.280

7.  Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors.

Authors:  Julia Rousseau; Rolf F Barth; Manuel Fernandez; Jean-François Adam; Jacques Balosso; François Estève; Hélène Elleaume
Journal:  J Neurooncol       Date:  2009-12-11       Impact factor: 4.130

8.  External irradiation models for intracranial 9L glioma studies.

Authors:  Sandrine Vinchon-Petit; Delphine Jarnet; Eric Jadaud; Loïc Feuvret; Emmanuel Garcion; Philippe Menei
Journal:  J Exp Clin Cancer Res       Date:  2010-11-08

9.  Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival.

Authors:  C G Robinson; J M Palomo; G Rahmathulla; M McGraw; J Donze; L Liu; M A Vogelbaum
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

Review 10.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

View more
  2 in total

Review 1.  Magnetic resonance imaging-guided radiation therapy using animal models of glioblastoma.

Authors:  Christian Vanhove; Ingeborg Goethals
Journal:  Br J Radiol       Date:  2019-01-17       Impact factor: 3.039

Review 2.  Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy.

Authors:  Mihaela Ghita; Victoria Dunne; Gerard G Hanna; Kevin M Prise; Jaqueline P Williams; Karl T Butterworth
Journal:  Br J Radiol       Date:  2019-02-13       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.